T3	Effect 55 75	hepatic angiosarcoma
T4	Subject 79 87	patients
T5	Treatment 94 130	long-term cyclophosphamide treatment
T7	Duration 94 103	long-term
T8	Drug 104 120	cyclophosphamide
T6	Adverse_event 88 93	after
E1	Adverse_event:T6